Collection's Items (Sorted by Year in Descending order): 1 to 20 of 2282
| Preview | Issue Date | Title | Author(s) |
| 2024 | Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study | McLean, L. S.; Lim, A. M.; Bressel, M.; Lee, J.; Ladwa, R.; Guminski, A. D.; Hughes, B.; Bowyer, S.; Briscoe, K.; Harris, S.; Kukard, C.; Zielinski, R.; Alamgeer, M.; Carlino, M.; Mo, Jeremy; Park, J. J.; Khattak, M. A.; Day, F.; Rischin, D.; Carlino, Matteo S.; Mo, Jeremy | |
| 2024 | Use of anticoagulation for thromboembolic prophylaxis in patients with atrial high-rate episodes on device monitoring: A narrative review | Leung, Alice N. W.; Bhat, Aditya; Leung, Alice N. W.; Bhat, Aditya | |
| 2024 | First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) in patients (pts) with microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): 64-month (mo) follow-up from CheckMate 142 | Lenz, H. J.; Overman, M. J.; Van Cutsem, E.; Limon, M. L.; Wong, Mark; Hendlisz, A.; Aglietta, M.; Garcia-Alfonso, P.; Neyns, B.; Gelsomino, F.; Cardin, D. B.; Dragovich, T.; Shah, U.; McCraith, S.; Wang, R.; Lei, M.; Yao, J.; Jin, L.; Lonardi, S.; Wong, Mark | |
| 2024 | A classic and an unusual presentation of atheroembolic renal disease | Teo, Kai Z.; Tarafdar, Surjit; Cheng, J.; Bayly, Angela; Viswanathan, Seethalakshmi; Teo, Kai Z.; Tarafdar, Surjit; Bayly, Angela; Viswanathan, Seethalakshmi | |
| 2024 | Seasonal patterns of toxicity in melanoma patients treated with combination anti-PD-1 and anti-CTLA-4 immunotherapy | Rogiers, A.; Dimitriou, F.; Lobon, I.; Harvey, C.; Vergara, I. A.; Pires da Silva, Ines; Lo, S. N.; Scolyer, Richard A.; Carlino, Matteo S.; Menzies, A. M.; Long, G. V.; Pires da Silva, Ines; Carlino, Matteo S. | |
| 2024 | SAFFRON-103: a phase Ib study of sitravatinib plus tislelizumab in anti-PD-(L)1 refractory/resistant advanced melanoma | Wang, X.; Pan, H.; Cui, J.; Chen, X.; Yoon, Won-Hee; Carlino, Matteo S.; Li, X.; Li, H.; Zhang, J.; Sun, J.; Guo, J.; .; Yoon, Won-Hee; Carlino, Matteo S. | |
| 2024 | ASO Visual Abstract: Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging | Gjorup, C. A.; Woodford, R.; Li, I.; Carlino, Matteo S.; Ch'ng, S.; Chung, D.; Hsiao, E.; Lo, S. N.; London, K.; Long, G. V.; Menzies, A. M.; Nieweg, O. E.; Pennington, T. E.; Rtshiladze, M. A.; Saw, R. P. M.; Scolyer, R. A.; Shannon, K. F.; Spillane, A. J.; Stretch, J. R.; Thompson, J. F.; Varey, Alexander H. R.; van Akkooi, A. C. J.; Carlino, Matteo S.; Varey, Alexander H. R. | |
| 2024 | The effectiveness and safety of lifestyle medicine and integrative therapies in inflammatory arthritis: an umbrella review using a hierarchical evidence gathering approach | Lin, J.; Liu, J.; O'Fee, A.; Pandey, C.; Benna-Doyle, S.; Maunder, A.; Rao, V.; Alesi, S.; Ng, Beverly C. K.; Ee, C.; Ng, Beverly C. K. | |
| 2024 | Qualitative and quantitative evaluation of an innovative primary and secondary diabetes clinic in Western Sydney | Ravi, Sumathy; Meyerowitz-Katz, Gideon; Murugesan, Anandhi; Ayre, J.; Jayaballa, Rajini; Rintoul, D.; Sarkis, M.; McCaffery, K.; Maberly, Glen F.; Bonner, Carissa; Ravi, Sumathy; Meyerowitz-Katz, Gideon; Murugesan, Anandhi; Jayaballa, Rajini; Maberly, Glen F. | |
| 2024 | Safety and efficacy of physician-administered balanced-sedation for the endoscopic mucosal resection of large non-pedunculated colorectal polyps | Gupta, Sunil; Kurup, Rajiv; Shahidi, Neal; Vosko, Sergei; McKay, Owen; Zahid, Simmi; Whitfield, Anthony M.; Lee, Eric Y.; Williams, Stephen J.; Burgess, Nicholas G.; Bourke, Michael J.; Gupta, Sunil; Kurup, Rajiv; Shahidi, Neal; Vosko, Sergei; McKay, Owen; Zahid, Simmi; Whitfield, Anthony M.; Lee, Eric Y. T.; Williams, Stephen J.; Burgess, Nicholas G.; Bourke, Michael J. | |
| 2024 | Assessing and managing frailty in advanced heart failure: An International Society for Heart and Lung Transplantation consensus statement | Denfeld, Q. E.; Jha, S. R.; Fung, E.; Jaarsma, T.; Maurer, M. S.; Reeves, G. R.; Afilalo, J.; Beerli, N.; Bellumkonda, L.; De Geest, S.; Gorodeski, E. Z.; Joyce, E.; Kobashigawa, J.; Mauthner, O.; McDonagh, Julee; Uchmanowicz, I.; Dickson, V. V.; Lindenfeld, J.; Macdonald, P.; McDonagh, Julee | |
| 2024 | Aggregatibacter actinomycetemcomitans pacemaker lead infection-A case report and literature review | Zhang, H.; Sivalingam, V.; Qian, Pierre C.; Sivagnanam, S.; Zhang, H.; Sivalingam, V.; Qian, Pierre C.; Sivagnanam, S. | |
| 2024 | A case of APRT deficiency - a rare cause of nephrolithiasis and kidney failure | Seif, Jonathan; Viswanathan, Seethalakshmi; Seif, Jonathan; Viswanathan, Seethalakshmi | |
| 2024 | Nivolumab plus cabozantinib (N+C) vs sunitinib (S) for previously untreated advanced renal cell carcinoma (aRCC): Results from 55-month follow-up of the CheckMate 9ER trial | Bourlon, M. T.; Escudier, B.; Burotto, M.; Powles, T.; Apolo, A. B.; Shah, A. Y.; Porta, C.; Suarez, C.; Barrios, C. H.; Richardet, M.; Gurney, Howard; Kessler, E. R.; Tomita, Y.; Bedke, J.; Wang, F.; Wang, P.; Panzica, J.; Fedorov, V.; Motzer, R. J.; Choueiri, T. K.; Gurney, Howard | |
| 2024 | Hidden danger: maize starch excipient allergy | Lukose, L.; Seth, S.; Sud, Kamal; Nankivell, Brian J.; Nicdao, Mary Ann; Castelino, Ronald L.; Sud, Kamal; Nankivell, Brian J.; Nicdao, Mary Ann; Castelino, Ronald L. | |
| 2024 | Correlation of flow cytometric measurable residual disease (FC-MRD) with molecular MRD and clinical outcome at one year in adult B-acute lymphoblastic leukaemia (B-ALL) and acute myeloid leukaemia (AML) | van der Linde, R.; Gatt, P. N.; Smith, S.; Fernandez, M.; Vaughan, Lachlin; Blyth, Emily M.; Curnow, Jennifer; Brown, David A.; Tegg, Elizabeth; Sasson, Sarah C.; Vaughan, Lachlin; Blyth, Emily M.; Curnow, Jennifer; Brown, David A.; Tegg, Elizabeth; Sasson, Sarah C. | |
| 2024 | Real world efficacy and toxicity of consolidation durvalumab following chemoradiotherapy in older Australian patients with unresectable stage III non-small cell lung cancer | Stevens, S.; Nindra, U.; Shahnam, Adel; Wei, Joe; Bray, V.; Pal, A.; Yip, P. Y.; Linton, A.; Blinman, P.; Nagrial, Adnan; Lee, J.; Boyer, M.; Kao, S.; Shahnam, Adel; Wei, Joe; Nagrial, Adnan | |
| 2024 | Charlson comorbidity index strongly correlates with subclinical myocardial dysfunction and predicts cardiovascular outcomes in patients with systemic sclerosis | Khanna, Shaun; Mishra, Shiva R.; Thakur, Arunav; Bhat, Aditya; Chen, Henry H.; Gan, Gary C. H.; Tan, Timothy C.; Khanna, Shaun; Mishra, Shiva R.; Thakur, Arunav; Bhat, Aditya; Chen, Henry H.; Gan, Gary C. H.; Tan, Timothy C. | |
| 2024 | Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer-Real World Outcomes After Two Years of Therapy (COPILOT) | Fantoni, A.; Warburton, L.; Solomon, B.; Alexander, M.; Maddula, Meghana; Brown, Lauren J.; da Silva, Ines P.; Nagrial, Adnan M.; Abu Al-Hial, F.; Itchins, M.; Pavlakis, N.; Bowyer, S.; Maddula, Meghana; Brown, Lauren J.; da Silva, Ines P.; Nagrial, Adnan M. | |
| 2024 | Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Long- term outcomes from the JAVELIN Bladder 100 trial in patients (pts) with high body mass index (BMI) | Aragon-Ching, J. B.; Petrylak, D. P.; Sridhar, Srikala S.; Gupta, S.; Grivas, P.; Powles, T.; Gurney, Howard; Jacob, N.; Tyroller, K.; Guenther, S.; Bellmunt, J.; Sridhar, Srikala S.; Gurney, Howard | |
Collection's Items (Sorted by Year in Descending order): 1 to 20 of 2282
